查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1586192

脂肪团治疗市场：按类型、手术类型、最终用途分类 - 2025-2030 年全球预测

Cellulite Treatment Market by Type (Edematous Cellulite, Hard Cellulite, Soft Cellulite), Procedure Type (Minimally Invasive, Non-Invasive, Topical), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年消脂治疗市场的市场规模为35.8亿美元，预计2024年将达到39.1亿美元，复合年增长率为9.59%，到2030年将达到68.1亿美元。

由于人们对美容和技术进步的兴趣日益浓厚，脂肪团治疗市场正在不断扩大。脂肪团是一种美容状况，其特征是由于皮肤表面下的脂肪沉积而导致皮肤出现凹痕，主要影响女性。对脂肪团治疗的需求源于人们对美容标准和自我形象的认识不断提高，迫使人们寻求改善皮肤外观。此领域的应用范围从局部治疗、雷射治疗和射频等微创手术，到皮下切除等手术选择。最终用途领域包括皮肤科和美容诊所、医疗水疗中心以及使用家用设备的家庭护理。

主要市场统计
基准年[2023] 35.8亿美元
预测年份 [2024] 39.1亿美元
预测年份 [2030] 68.1亿美元
复合年增长率（%） 9.59%

推动市场成长的关键因素包括可支配收入的增加、健康意识的提高以及提高治疗效果和减少停机时间的技术创新。然而，潜在的成长机会在于先进技术的整合，例如人工智慧主导的诊断和治疗工具，以及透过非侵入性、负担得起和易于获得的选项来扩展产品系列。儘管有这些机会，但市场仍面临一些限制，例如先进治疗的高成本、潜在的副作用和治疗功效的可变性，以及可能限制市场进入的严格监管要求。

为了掌握市场机会，公司应专注于研发投资，创新更安全、更有效、更具成本效益的治疗方法。与皮肤科医生合作进行临床试验并获得建议可以进一步提高您产品的可信度。另一个有技术创新空间的领域是利用人工智慧和机器学习来制定适合个人皮肤类型和状况的个人化治疗计划。此外，全球对远距皮肤科服务的推动可能会为市场扩张开闢新的途径，特别是在服务不足的地区。市场竞争激烈且充满活力，非侵入性解决方案的趋势凸显了持续创新以及符合美容和健康消费者趋势的重要性。

市场动态：揭示快速发展的脂肪团治疗市场的关键市场洞察

供需的动态交互作用正在改变脂肪团治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 肥胖盛行率上升
    • 消费者对外观的关注度不断提高
    • 微创手术受消费者欢迎
  • 市场限制因素
    • 对脂肪团治疗的认识与可近性有限
  • 市场机会
    • 开发局部抗脂肪霜和射频治疗
    • 经济区的医疗旅游提供负担得起的整容手术
  • 市场挑战
    • 手术或治疗可能产生的副作用

波特的五力：驾驭脂肪团治疗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解脂肪团治疗市场的外部影响

外部宏观环境因素在塑造脂肪团治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解脂肪团治疗市场的竞争状况

对脂肪团治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵性消脂治疗市场供应商的绩效评估

FPNV 定位矩阵是评估脂肪团治疗市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了脂肪团治疗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对脂肪团治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 肥胖率上升
      • 消费者对外观的兴趣日益浓厚
      • 微创手术受消费者欢迎
    • 抑制因素
      • 对脂肪团治疗的认识与可近性有限
    • 机会
      • 开发局部抗脂肪霜和射频疗法
      • 提供负担得起的整容手术的经济体的医疗旅游
    • 任务
      • 手术或治疗可能产生的副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章脂肪团治疗市场：依类型

  • 水肿性脂肪团
  • 硬脂肪团
  • 软脂肪团

第七章依手术类型分類的脂肪团治疗市场

  • 微创
  • 非侵入性
  • 话题

第八章脂肪团治疗市场：依最终用途

  • 美容整形外科中心
  • 皮肤科诊所
  • 医院

第九章北美及南美消脂治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太脂肪团治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲消脂治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie, Inc.
  • Alma Lasers Ltd.
  • Beijing Sincoheren S & T Development Co., Ltd.
  • Candela Corporation
  • Cutera, Inc.
  • Cymedics
  • Cymedics GmbH & Co. KG
  • Cynosure, Inc.
  • Endo-Systems LLC
  • Hologic Inc.
  • Inceler Medikal Co. Ltd.
  • Johnson & Johnson Services, Inc.
  • Merz Pharma
  • Merz Pharma GmbH & Co. KGaA
  • Nestle SA
  • Shanghai Fosun Pharmaceutical（Group）Co. Ltd
  • Skinrex Co., Ltd.
  • Venus Concept Inc.
  • Zimmer Aesthetics, Inc.
Product Code: MRR-F927BA4624EC

The Cellulite Treatment Market was valued at USD 3.58 billion in 2023, expected to reach USD 3.91 billion in 2024, and is projected to grow at a CAGR of 9.59%, to USD 6.81 billion by 2030.

The cellulite treatment market is broadening, driven by increasing aesthetic concerns and technological advancements. Cellulite, a cosmetic condition marked by dimpled skin due to fat deposit beneath the skin's surface, primarily affects women. The necessity for cellulite treatment stems from heightened beauty standards and self-image consciousness, compelling individuals to seek improved skin appearance. Applications in this domain range from topical treatments and minimally invasive procedures like laser therapy and radiofrequency, to surgical options such as subcision. End-use sectors predominantly include dermatological and cosmetic clinics, medical spas, and homecare settings equipped with at-home devices.

KEY MARKET STATISTICS
Base Year [2023] USD 3.58 billion
Estimated Year [2024] USD 3.91 billion
Forecast Year [2030] USD 6.81 billion
CAGR (%) 9.59%

Key factors driving market growth include rising disposable incomes, an increase in health and wellness awareness, and technological innovations offering enhanced treatment efficacy and reduced downtime. However, potential growth opportunities lie in integrating advanced technologies like AI-driven diagnostic and treatment tools, and expanding product portfolios with non-invasive, affordable, and accessible options. Despite these opportunities, the market faces constraints such as high costs of advanced treatments, possible side effects and varied treatment efficacy, and stringent regulatory requirements that may limit market access.

To capitalize on market opportunities, companies should focus on R&D investments to innovate safer, more effective, and cost-efficient treatments. Collaborations with dermatologists for clinical trials and gaining endorsements can further bolster product credibility. Another area ripe for innovation is personalized treatment plans that cater to individual skin types and conditions, leveraging AI and machine learning for precise customization. Furthermore, the global push towards tele-dermatology services could open new avenues for market expansion, especially in underserved regions. The nature of the cellulite treatment market is competitive and dynamic, with a trend towards non-invasive solutions, highlighting the importance of continuous innovation and alignment with consumer trends in beauty and wellness.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cellulite Treatment Market

The Cellulite Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the prevalence of obesity
    • Increasing consumer focus on physical appearance
    • Popularity of minimally invasive procedures among consumers
  • Market Restraints
    • Limited awareness and accessibility of cellulite treatments
  • Market Opportunities
    • Development of topical anti-cellulite creams and radiofrequency therapy
    • Medical tourism in economies delivering affordable aesthetic surgical procedures
  • Market Challenges
    • Possible side effects of surgeries and procedures

Porter's Five Forces: A Strategic Tool for Navigating the Cellulite Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cellulite Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cellulite Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cellulite Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cellulite Treatment Market

A detailed market share analysis in the Cellulite Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cellulite Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cellulite Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cellulite Treatment Market

A strategic analysis of the Cellulite Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cellulite Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie, Inc., Alma Lasers Ltd., Beijing Sincoheren S & T Development Co., Ltd., Candela Corporation, Cutera, Inc., Cymedics, Cymedics GmbH & Co. KG, Cynosure, Inc., Endo-Systems LLC, Hologic Inc., Inceler Medikal Co. Ltd., Johnson & Johnson Services, Inc., Merz Pharma, Merz Pharma GmbH & Co. KGaA, Nestle S.A., Shanghai Fosun Pharmaceutical (Group) Co. Ltd, Skinrex Co., Ltd., Venus Concept Inc., and Zimmer Aesthetics, Inc..

Market Segmentation & Coverage

This research report categorizes the Cellulite Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Edematous Cellulite, Hard Cellulite, and Soft Cellulite.
  • Based on Procedure Type, market is studied across Minimally Invasive, Non-Invasive, and Topical.
  • Based on End-Use, market is studied across Cosmetic Surgery Centers, Dermatology Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the prevalence of obesity
      • 5.1.1.2. Increasing consumer focus on physical appearance
      • 5.1.1.3. Popularity of minimally invasive procedures among consumers
    • 5.1.2. Restraints
      • 5.1.2.1. Limited awareness and accessibility of cellulite treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of topical anti-cellulite creams and radiofrequency therapy
      • 5.1.3.2. Medical tourism in economies delivering affordable aesthetic surgical procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Possible side effects of surgeries and procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cellulite Treatment Market, by Type

  • 6.1. Introduction
  • 6.2. Edematous Cellulite
  • 6.3. Hard Cellulite
  • 6.4. Soft Cellulite

7. Cellulite Treatment Market, by Procedure Type

  • 7.1. Introduction
  • 7.2. Minimally Invasive
  • 7.3. Non-Invasive
  • 7.4. Topical

8. Cellulite Treatment Market, by End-Use

  • 8.1. Introduction
  • 8.2. Cosmetic Surgery Centers
  • 8.3. Dermatology Clinics
  • 8.4. Hospitals

9. Americas Cellulite Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cellulite Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cellulite Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie, Inc.
  • 2. Alma Lasers Ltd.
  • 3. Beijing Sincoheren S & T Development Co., Ltd.
  • 4. Candela Corporation
  • 5. Cutera, Inc.
  • 6. Cymedics
  • 7. Cymedics GmbH & Co. KG
  • 8. Cynosure, Inc.
  • 9. Endo-Systems LLC
  • 10. Hologic Inc.
  • 11. Inceler Medikal Co. Ltd.
  • 12. Johnson & Johnson Services, Inc.
  • 13. Merz Pharma
  • 14. Merz Pharma GmbH & Co. KGaA
  • 15. Nestle S.A.
  • 16. Shanghai Fosun Pharmaceutical (Group) Co. Ltd
  • 17. Skinrex Co., Ltd.
  • 18. Venus Concept Inc.
  • 19. Zimmer Aesthetics, Inc.

LIST OF FIGURES

  • FIGURE 1. CELLULITE TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. CELLULITE TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CELLULITE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CELLULITE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CELLULITE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CELLULITE TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CELLULITE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CELLULITE TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY EDEMATOUS CELLULITE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY HARD CELLULITE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY SOFT CELLULITE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY COSMETIC SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CELLULITE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES CELLULITE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 146. CELLULITE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. CELLULITE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023